| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.50e-05 | 124 | 52 | 5 | GO:0007229 | |
| Domain | F-box | 8.60e-04 | 67 | 52 | 3 | PF00646 | |
| Domain | Disintegrin_CS | 8.90e-04 | 16 | 52 | 2 | IPR018358 | |
| Domain | FBOX | 1.06e-03 | 72 | 52 | 3 | PS50181 | |
| Domain | ADAM_CR | 1.13e-03 | 18 | 52 | 2 | PF08516 | |
| Domain | F-box_dom | 1.19e-03 | 75 | 52 | 3 | IPR001810 | |
| Domain | PDEase | 1.26e-03 | 19 | 52 | 2 | IPR023088 | |
| Domain | - | 1.40e-03 | 20 | 52 | 2 | 4.10.70.10 | |
| Domain | PDEase_I | 1.54e-03 | 21 | 52 | 2 | PF00233 | |
| Domain | Disintegrin | 1.54e-03 | 21 | 52 | 2 | PF00200 | |
| Domain | PDEASE_I | 1.54e-03 | 21 | 52 | 2 | PS00126 | |
| Domain | PDEase_CS | 1.54e-03 | 21 | 52 | 2 | IPR023174 | |
| Domain | DISIN | 1.54e-03 | 21 | 52 | 2 | SM00050 | |
| Domain | - | 1.69e-03 | 22 | 52 | 2 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 1.85e-03 | 23 | 52 | 2 | IPR002073 | |
| Domain | HDc | 2.02e-03 | 24 | 52 | 2 | SM00471 | |
| Domain | HD/PDEase_dom | 2.02e-03 | 24 | 52 | 2 | IPR003607 | |
| Domain | ACR | 2.55e-03 | 27 | 52 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 2.55e-03 | 27 | 52 | 2 | IPR006586 | |
| Domain | Peptidase_M12B_N | 5.27e-03 | 39 | 52 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 5.27e-03 | 39 | 52 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 5.54e-03 | 40 | 52 | 2 | PS00427 | |
| Domain | Reprolysin | 5.54e-03 | 40 | 52 | 2 | PF01421 | |
| Domain | ADAM_MEPRO | 5.54e-03 | 40 | 52 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 5.54e-03 | 40 | 52 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 5.54e-03 | 40 | 52 | 2 | IPR001590 | |
| Domain | Disintegrin_dom | 5.82e-03 | 41 | 52 | 2 | IPR001762 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 7.65e-05 | 28 | 42 | 3 | M47655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 9.44e-05 | 30 | 42 | 3 | M47718 | |
| Pubmed | 1.32e-06 | 529 | 53 | 8 | 14621295 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29856966 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 16757476 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 18782782 | ||
| Pubmed | Differential effects of SUMO1 and SUMO2 on circadian protein PER2 stability and function. | 1.36e-05 | 4 | 53 | 2 | 34257372 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 30425162 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 35100259 | ||
| Pubmed | 2.10e-05 | 1285 | 53 | 10 | 35914814 | ||
| Pubmed | Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U. | 2.27e-05 | 5 | 53 | 2 | 11850407 | |
| Pubmed | O-GlcNAcylation Signal Mediates Proteasome Inhibitor Resistance in Cancer Cells by Stabilizing NRF1. | 2.27e-05 | 5 | 53 | 2 | 29941490 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 26903623 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 19106159 | ||
| Pubmed | Control of mammalian circadian rhythm by CKIepsilon-regulated proteasome-mediated PER2 degradation. | 2.27e-05 | 5 | 53 | 2 | 15767683 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 17462724 | ||
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 15496141 | ||
| Pubmed | Systemwide disassembly and assembly of SCF ubiquitin ligase complexes. | 8.29e-05 | 55 | 53 | 3 | 37028429 | |
| Pubmed | 9.86e-05 | 963 | 53 | 8 | 28671696 | ||
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 8938438 | ||
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 23785138 | ||
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 16183868 | ||
| Pubmed | 1.76e-04 | 13 | 53 | 2 | 37070251 | ||
| Pubmed | 1.76e-04 | 13 | 53 | 2 | 8557689 | ||
| Pubmed | 2.05e-04 | 14 | 53 | 2 | 17463251 | ||
| Pubmed | 2.49e-04 | 1103 | 53 | 8 | 34189442 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 2.57e-04 | 372 | 53 | 5 | 22939624 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 2.66e-04 | 375 | 53 | 5 | 32788342 | |
| Pubmed | 3.09e-04 | 1139 | 53 | 8 | 36417873 | ||
| Pubmed | 3.83e-04 | 19 | 53 | 2 | 21572392 | ||
| Pubmed | 3.87e-04 | 407 | 53 | 5 | 12693553 | ||
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 3.96e-04 | 226 | 53 | 4 | 25900982 | |
| Pubmed | ¹H NMR metabolic profiling of plasma reveals additional phenotypes in knockout mouse models. | 4.25e-04 | 20 | 53 | 2 | 25849460 | |
| Pubmed | 4.25e-04 | 20 | 53 | 2 | 21068328 | ||
| Pubmed | 4.65e-04 | 653 | 53 | 6 | 22586326 | ||
| Pubmed | 4.70e-04 | 21 | 53 | 2 | 27740716 | ||
| Pubmed | 4.70e-04 | 21 | 53 | 2 | 37005481 | ||
| Pubmed | 4.70e-04 | 21 | 53 | 2 | 12670868 | ||
| Pubmed | 4.72e-04 | 655 | 53 | 6 | 35819319 | ||
| Pubmed | 5.37e-04 | 245 | 53 | 4 | 19521500 | ||
| Pubmed | 5.65e-04 | 23 | 53 | 2 | 30814516 | ||
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | 6.11e-04 | 450 | 53 | 5 | 16751776 | |
| Pubmed | Regulation of mesenchymal-to-epithelial transition by PARAXIS during somitogenesis. | 6.16e-04 | 24 | 53 | 2 | 24038871 | |
| Pubmed | 6.17e-04 | 451 | 53 | 5 | 30033366 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 6.51e-04 | 258 | 53 | 4 | 37794589 | |
| Pubmed | 6.68e-04 | 25 | 53 | 2 | 17307970 | ||
| Pubmed | 6.68e-04 | 25 | 53 | 2 | 20301702 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 7.97e-04 | 1005 | 53 | 7 | 19615732 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 8.62e-04 | 486 | 53 | 5 | 30940648 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 8.95e-04 | 281 | 53 | 4 | 28706196 | |
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 9.97e-04 | 128 | 53 | 3 | 25332235 | |
| Pubmed | FBXO38 Ubiquitin Ligase Controls Centromere Integrity via ZXDA/B Stability. | 1.10e-03 | 32 | 53 | 2 | 35813202 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.12e-03 | 774 | 53 | 6 | 15302935 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 1.16e-03 | 135 | 53 | 3 | 31077711 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.22e-03 | 1082 | 53 | 7 | 38697112 | |
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 1.31e-03 | 35 | 53 | 2 | 26091241 | |
| Pubmed | 1.37e-03 | 1431 | 53 | 8 | 37142655 | ||
| Pubmed | 1.46e-03 | 146 | 53 | 3 | 29688375 | ||
| Pubmed | 1.47e-03 | 37 | 53 | 2 | 10531035 | ||
| Pubmed | 1.48e-03 | 549 | 53 | 5 | 38280479 | ||
| GeneFamily | Phosphodiesterases | 1.21e-03 | 24 | 39 | 2 | 681 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.54e-03 | 27 | 39 | 2 | 47 | |
| GeneFamily | Cyclins|F-boxes other | 3.19e-03 | 39 | 39 | 2 | 560 | |
| GeneFamily | LIM domain containing | 7.18e-03 | 59 | 39 | 2 | 1218 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 7.17e-08 | 179 | 53 | 6 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.55e-06 | 165 | 53 | 5 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.55e-06 | 165 | 53 | 5 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 191 | 53 | 5 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 191 | 53 | 5 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 197 | 53 | 5 | bed8a9b73af5caee51b1232b31c24a59353658df | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 197 | 53 | 5 | b7d5073d44aa1e2cb83ea8d8104c5ed662665755 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-06 | 198 | 53 | 5 | cc5ca64749e2f4f1d373d9472824df85741702b7 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-06 | 198 | 53 | 5 | d4d66f19df078bfc3a83d4664aaf9c7789bde1a5 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-06 | 200 | 53 | 5 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC2|Dendritic_cell / Region, Cell class and subclass | 2.11e-05 | 45 | 53 | 3 | 5488dced1d338166f3021509ebe8673e03995978 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-05 | 159 | 53 | 4 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-05 | 161 | 53 | 4 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.34e-05 | 164 | 53 | 4 | 2c48c6e4eeee845f0563982d0bfa2a176ca5ef61 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.55e-05 | 166 | 53 | 4 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 4.87e-05 | 169 | 53 | 4 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 4.99e-05 | 170 | 53 | 4 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 4.99e-05 | 170 | 53 | 4 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-05 | 170 | 53 | 4 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-05 | 170 | 53 | 4 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-05 | 172 | 53 | 4 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.22e-05 | 172 | 53 | 4 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-05 | 172 | 53 | 4 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 5.34e-05 | 173 | 53 | 4 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 174 | 53 | 4 | 6ca9433d398aa3b48ecdc522dd545119e7c77dd4 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.46e-05 | 174 | 53 | 4 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-05 | 175 | 53 | 4 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.71e-05 | 176 | 53 | 4 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.71e-05 | 176 | 53 | 4 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 5.96e-05 | 178 | 53 | 4 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 6.50e-05 | 182 | 53 | 4 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 6.50e-05 | 182 | 53 | 4 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | P03|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.92e-05 | 185 | 53 | 4 | a07dbe1f76e40734a28826423a5cc64b8e56af5e | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.07e-05 | 186 | 53 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.22e-05 | 187 | 53 | 4 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.22e-05 | 187 | 53 | 4 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.22e-05 | 187 | 53 | 4 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.37e-05 | 188 | 53 | 4 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 7.52e-05 | 189 | 53 | 4 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.68e-05 | 190 | 53 | 4 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | T_cells-Effector_memory_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 7.68e-05 | 190 | 53 | 4 | 1af91fe0ee2c924e12f4db93c793e7af475d8f80 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.83e-05 | 191 | 53 | 4 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.15e-05 | 193 | 53 | 4 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.32e-05 | 194 | 53 | 4 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.32e-05 | 194 | 53 | 4 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.32e-05 | 194 | 53 | 4 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.32e-05 | 194 | 53 | 4 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | Severe-CD8+_T_activated|Severe / Disease group and Cell class | 8.83e-05 | 197 | 53 | 4 | bb1e3e1d841c2c7141eb1099e7755860b168b6fc | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.83e-05 | 197 | 53 | 4 | ca6bce1a92c6326f41a6300c31da02386bafa152 | |
| ToppCell | Severe-CD8+_T_activated|World / Disease group and Cell class | 9.00e-05 | 198 | 53 | 4 | 5ff98c9b6c8c6863767b76c7745f263568f86acc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-05 | 198 | 53 | 4 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.00e-05 | 198 | 53 | 4 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.00e-05 | 198 | 53 | 4 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | 5ab588808c1fc384019413401ab4bf9bc06bf529 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-cDC-DCs|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.36e-05 | 200 | 53 | 4 | 0576e34dc9a6adae5782659511d641781c6a44ed | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-cDC-DCs-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.36e-05 | 200 | 53 | 4 | b074b30cd7bb893c24cd49af1b2126825c59eef7 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-DCs|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.36e-05 | 200 | 53 | 4 | cae0e62804e41828e9cf74b9e3452c43a12bc87d | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.36e-05 | 200 | 53 | 4 | 337daee31dd5a277b9ef1dbd7fd6660371636084 | |
| ToppCell | Biopsy_Other_PF-Immune-cDCs|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.36e-05 | 200 | 53 | 4 | 8e455f685f0a9c63e83d6d339d7767f0e9841c6e | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 5.37e-06 | 199 | 51 | 6 | 1469_DN | |
| Disease | copine-1 measurement | 4.07e-04 | 17 | 52 | 2 | EFO_0008102 | |
| Disease | Nodular glomerulosclerosis | 2.39e-03 | 41 | 52 | 2 | C0017667 | |
| Disease | Diabetic Nephropathy | 2.75e-03 | 44 | 52 | 2 | C0011881 | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 2.87e-03 | 45 | 52 | 2 | DOID:5199 (biomarker_via_orthology) | |
| Disease | X-12063 measurement | 4.34e-03 | 186 | 52 | 3 | EFO_0021283 | |
| Disease | Hypertensive disease | 4.61e-03 | 190 | 52 | 3 | C0020538 | |
| Disease | aspartate aminotransferase measurement | 4.99e-03 | 904 | 52 | 6 | EFO_0004736 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 5.05e-03 | 60 | 52 | 2 | EFO_0020690 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 5.22e-03 | 61 | 52 | 2 | DOID:3587 (is_marker_for) | |
| Disease | serum gamma-glutamyl transferase measurement | 5.26e-03 | 914 | 52 | 6 | EFO_0004532 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPLHYLDQHNQNCLY | 376 | Q9H6S1 | |
| YCRLSPNHKVLHYGD | 576 | Q92556 | |
| YGANCYRKNPVHFQH | 381 | Q8IW19 | |
| CHYQHGHINSYLKPM | 161 | Q9Y297 | |
| DHCYYQGKLRGNPHS | 131 | O75078 | |
| YNALHLAAKYGHPQC | 116 | Q8TF21 | |
| ALQAYSVANKHGHYP | 361 | Q6ZUJ8 | |
| AYKHLNYGPHSCQQM | 1276 | Q96F81 | |
| KSCHQGLAYHYLQVP | 321 | Q9Y2H0 | |
| KNQAVCHDYDIHFYP | 126 | Q6ZRP7 | |
| NAGHACYLHKPQDFH | 246 | Q9BUJ0 | |
| HHCLQMPYKRNGGYF | 381 | Q86T65 | |
| AYGGCLVHLYNSHAL | 96 | Q8NGZ5 | |
| GYYSCVHFLHHNGKL | 181 | Q13478 | |
| ALHGEFYCKPHFQQL | 81 | Q9BT23 | |
| PKHHYPGCINLSFAY | 346 | Q9Y697 | |
| YFRQGHNCHKPDTYV | 516 | Q16288 | |
| LQKCHYHHGANPLYS | 1676 | Q9UKN7 | |
| HRYLHLLDGNENYPC | 436 | Q8N1G4 | |
| SHCHYYLQERSKGQP | 756 | O15055 | |
| KYNFPGNCHFLAVHN | 831 | Q7Z5P9 | |
| YYLSLHHGKGCAALI | 131 | A6NFU8 | |
| GKYKNPYHNQIHAAD | 216 | Q01064 | |
| CHDLDHPGYNNTYQI | 351 | O76083 | |
| HYPAKEQYGDTLHFC | 306 | Q8TCJ0 | |
| CIKYLAIYNCPHLHN | 401 | Q6PIJ6 | |
| HILNYYRTGKLHCPA | 66 | P48547 | |
| RGHCPQLAAYVHYAF | 826 | Q96HP0 | |
| CDLLASYQKGHHPAQ | 416 | Q96Q40 | |
| HYHNKQYRPQKGGIC | 211 | Q53EU6 | |
| NGALCHFPFLYNNHN | 416 | P02751 | |
| VQPGHCYHLYNGLRA | 606 | Q9H2U1 | |
| DHPNIQNHCHYRGYV | 106 | Q13443 | |
| AHNAPCAKGHLGDYQ | 81 | O75578 | |
| NPLSYHKVLCHGKYF | 81 | P22680 | |
| PHNHLYCQQYAEVKY | 186 | Q15006 | |
| KHLILVVNYSCPNHY | 686 | Q7L014 | |
| YLHNFQCKHGAIPVT | 496 | P51530 | |
| APCHYAHKLAYLVGQ | 851 | Q7Z3Z3 | |
| NALAHYAYLCGQHGV | 716 | Q3ZCN5 | |
| PNHAVVHGNLACVYY | 256 | O15294 | |
| EKHHNQPYCGIAPYI | 31 | P08621 | |
| HCYLHVNQKYLGTPE | 326 | P12757 | |
| KLAYGGHQYHASCAN | 1281 | Q9UMZ2 | |
| LGHKANHSFTPNCIY | 291 | Q8WTS6 | |
| KDYPQYCQHLASISH | 966 | A5YKK6 | |
| LYDLYAVCNHHGNLQ | 651 | Q70EL4 | |
| YHCVYHFVSAPKANA | 216 | Q9Y639 | |
| CHYTSGNKGYIKQHL | 646 | Q8TCN5 | |
| QANRPHCVPDYHKQY | 486 | Q15942 | |
| AICNYNAHYKNHPKY | 91 | P0DMS9 | |
| PVRLKCHPLANYHYA | 871 | Q96PN7 | |
| HSIYKNGYCPNHPVI | 866 | Q96PU5 |